JP2018509890A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018509890A5 JP2018509890A5 JP2017540262A JP2017540262A JP2018509890A5 JP 2018509890 A5 JP2018509890 A5 JP 2018509890A5 JP 2017540262 A JP2017540262 A JP 2017540262A JP 2017540262 A JP2017540262 A JP 2017540262A JP 2018509890 A5 JP2018509890 A5 JP 2018509890A5
- Authority
- JP
- Japan
- Prior art keywords
- δ133p53β
- isoform
- δ133p53γ
- pluripotent stem
- induced pluripotent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102000001708 Protein Isoforms Human genes 0.000 claims 22
- 108010029485 Protein Isoforms Proteins 0.000 claims 22
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims 19
- 238000000034 method Methods 0.000 claims 11
- 210000001082 somatic cell Anatomy 0.000 claims 5
- 239000012634 fragment Substances 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 3
- 208000018737 Parkinson disease Diseases 0.000 claims 2
- 230000032683 aging Effects 0.000 claims 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 238000012258 culturing Methods 0.000 claims 2
- 210000002950 fibroblast Anatomy 0.000 claims 2
- 108020004999 messenger RNA Proteins 0.000 claims 2
- 208000015122 neurodegenerative disease Diseases 0.000 claims 2
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 230000008672 reprogramming Effects 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 230000002463 transducing effect Effects 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 206010010099 Combined immunodeficiency Diseases 0.000 claims 1
- 201000010374 Down Syndrome Diseases 0.000 claims 1
- 206010013801 Duchenne Muscular Dystrophy Diseases 0.000 claims 1
- 208000011345 Duchenne and Becker muscular dystrophy Diseases 0.000 claims 1
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 1
- 208000015872 Gaucher disease Diseases 0.000 claims 1
- 208000028735 Gaucher disease type III Diseases 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 208000023105 Huntington disease Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 241001529936 Murinae Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 201000009628 adenosine deaminase deficiency Diseases 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 208000036556 autosomal recessive T cell-negative B cell-negative NK cell-negative due to adenosine deaminase deficiency severe combined immunodeficiency Diseases 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000002659 cell therapy Methods 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 229910003460 diamond Inorganic materials 0.000 claims 1
- 239000010432 diamond Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000002242 embryoid body Anatomy 0.000 claims 1
- 230000007717 exclusion Effects 0.000 claims 1
- 238000000684 flow cytometry Methods 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 238000003306 harvesting Methods 0.000 claims 1
- 210000004698 lymphocyte Anatomy 0.000 claims 1
- 208000010125 myocardial infarction Diseases 0.000 claims 1
- 108020004707 nucleic acids Proteins 0.000 claims 1
- 102000039446 nucleic acids Human genes 0.000 claims 1
- 150000007523 nucleic acids Chemical class 0.000 claims 1
- 230000001177 retroviral effect Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 208000002491 severe combined immunodeficiency Diseases 0.000 claims 1
- 208000002320 spinal muscular atrophy Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15305145 | 2015-01-30 | ||
| EP15305145.3 | 2015-01-30 | ||
| PCT/EP2016/052085 WO2016120493A1 (en) | 2015-01-30 | 2016-02-01 | Reprogramming method for producing induced pluripotent stem cells (ipsc) |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018509890A JP2018509890A (ja) | 2018-04-12 |
| JP2018509890A5 true JP2018509890A5 (enExample) | 2019-03-14 |
Family
ID=52589314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017540262A Pending JP2018509890A (ja) | 2015-01-30 | 2016-02-01 | 人工多能性幹細胞（ｉＰＳＣ）の生産を再プログラムする方法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US10767165B2 (enExample) |
| EP (1) | EP3250679B1 (enExample) |
| JP (1) | JP2018509890A (enExample) |
| WO (1) | WO2016120493A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11845960B2 (en) | 2016-09-12 | 2023-12-19 | President And Fellows Of Harvard College | Transcription factors controlling differentiation of stem cells |
| WO2018064460A1 (en) * | 2016-09-30 | 2018-04-05 | Mayo Foundation For Medical Education And Research | Viral vectors for nuclear reprogramming |
| WO2018204262A1 (en) * | 2017-05-01 | 2018-11-08 | President And Fellows Of Harvard College | Transcription factors controlling differentiation of stem cells |
| GB2564437B (en) * | 2017-07-10 | 2020-11-04 | Univ Brunel | Method of testing a gene therapy vector using induced pluripotent stem cells |
| WO2019108894A1 (en) | 2017-12-01 | 2019-06-06 | President And Fellows Of Harvard College | Methods and compositions for the production of oligodendrocyte progenitor cells |
| US11788131B2 (en) | 2018-04-06 | 2023-10-17 | President And Fellows Of Harvard College | Methods of identifying combinations of transcription factors |
| JP2022534295A (ja) * | 2019-05-30 | 2022-07-28 | イミュノルクス インターナショナル コーポレーション | ワクチン接種及び疾患治療法のための自己人工多能性幹細胞とのポックスウイルスの使用 |
| GB201909975D0 (en) * | 2019-07-11 | 2019-08-28 | Babraham Inst | Novel reprogramming method |
| US20220273591A1 (en) * | 2019-07-26 | 2022-09-01 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for determining risk of developing insulin resistance |
| CN114736872A (zh) * | 2022-05-06 | 2022-07-12 | 中国科学院动物研究所 | 提高多能干细胞性能的组合物、方法及其应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2690554T3 (es) * | 2008-03-17 | 2018-11-21 | The Scripps Research Institute | Enfoques químicos y genéticos combinados para la generación de células madre pluripotentes inducidas |
| KR101606943B1 (ko) * | 2008-06-27 | 2016-03-28 | 고쿠리츠 다이가쿠 호진 교토 다이가쿠 | 유도된 다능성 줄기 세포의 효율적인 확립 방법 |
| WO2010033991A2 (en) * | 2008-09-22 | 2010-03-25 | Children's Medical Center Corporation | Detection of human somatic cell reprogramming |
| EP2272979A1 (en) * | 2009-06-30 | 2011-01-12 | Centre National de la Recherche Scientifique (CNRS) | Method for testing a subject thought to be predisposed to having cancer |
| WO2011016588A1 (en) * | 2009-08-07 | 2011-02-10 | Kyoto University | Method of efficiently establishing induced pluripotent stem cells |
| JP2013541951A (ja) * | 2010-10-01 | 2013-11-21 | アメリカ合衆国 | ｐ５３アイソフォームによる幹細胞機能の操作 |
| US10920198B2 (en) * | 2015-01-30 | 2021-02-16 | Centre National De La Recherche Scientifique (Cnrs) | Delta133p53beta and delta133p53gamma isoforms are biomarkers of cancer stem cells |
-
2016
- 2016-02-01 EP EP16702146.8A patent/EP3250679B1/en active Active
- 2016-02-01 JP JP2017540262A patent/JP2018509890A/ja active Pending
- 2016-02-01 US US15/547,212 patent/US10767165B2/en active Active
- 2016-02-01 WO PCT/EP2016/052085 patent/WO2016120493A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018509890A5 (enExample) | ||
| Leng et al. | Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy | |
| FI3599251T3 (fi) | Cd20-antigeeniin kohdentuvan kimeerisen antigeenireseptorin rakentaminen ja sillä muunnettujen t-solujen aktiivisuuden tunnistaminen | |
| Mende et al. | CCND1–CDK4–mediated cell cycle progression provides a competitive advantage for human hematopoietic stem cells in vivo | |
| US20220401491A1 (en) | Mesenchymal stem cell expressing trail and cd, and use thereof | |
| Wu et al. | Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation | |
| Alonso-Martin et al. | Gene expression profiling of muscle stem cells identifies novel regulators of postnatal myogenesis | |
| O’Connor | Molecular profiles of cell‐to‐cell variation in the regenerative potential of mesenchymal stromal cells | |
| Liu et al. | Effects of SOX2 on proliferation, migration and adhesion of human dental pulp stem cells | |
| JP7449648B2 (ja) | リプログラミング前駆体組成物およびその使用方法 | |
| WO2021187380A1 (ja) | 不整脈源性心筋症患者由来の多能性幹細胞およびその利用ならびに不整脈源性心筋症治療用医薬 | |
| Wang et al. | NGF and TERT co-transfected BMSCs improve the restoration of cognitive impairment in vascular dementia rats | |
| TW202140779A (zh) | 唾液酸酶至癌細胞、免疫細胞及腫瘤微環境之輸送 | |
| Robert et al. | Oncolytic Adenovirus for the targeting of Paclitaxel-resistant breast Cancer stem cells | |
| Jahangiri et al. | Interleukin-12 inhibits tumor growth and metastasis promoted by tumor-associated mesenchymal stem cells in triple-negative breast cancer | |
| WO2004029301A3 (en) | Method for assaying replication of hbv and testing susceptibility to drugs | |
| Liu et al. | Distinct molecular basis for endothelial differentiation: gene expression profiles of human mesenchymal stem cells versus umbilical vein endothelial cells | |
| CN114728181B (zh) | 用于治疗hiv感染的长期存活的t细胞 | |
| CN104711240B (zh) | 禽呼肠孤病毒σA蛋白及其相关生物材料的应用 | |
| JP2016511636A (ja) | 消化管間質腫瘍（ｇｉｓｔ）を治療する方法及び組成物 | |
| CN114920824B (zh) | Tcr或其抗原结合片段及其应用 | |
| Tomizawa et al. | Dual gene expression in embryoid bodies derived from human induced pluripotent stem cells using episomal vectors | |
| CN104762274B (zh) | 禽呼肠孤病毒σNS蛋白及其相关生物材料的应用 | |
| Qian et al. | Lentivirus‐modified human umbilical cord mesenchymal stem cells maintain their pluripotency | |
| Canjuga et al. | Homing of mRNA-modified endothelial progenitor cells to inflamed endothelium |